Evolution of the Average Target: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Evolution of the Target Price: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Changes in Analyst Recommendations: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

578e4207bad997fadbee7.FIaaijwANQi_s_CXvQ29GFXy8bLLW2L4tNTz0Opj4HU.OdfizmVUXzjP5ZLyyWnacxmHt-2mAyWz8o2HlJ0hvwRes6uyEWgHPYr9lw~abd2cecc41849ddef90b7d9a7309f3e5

Add to a list
Analyst Opinion 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
- +40.23%
+54.23%
+38.82%
+33.95%
+32.17%
+3.82%
- - - -
- - - +30.29%
Average +33.36%
Weighted average by Cap. +38.36%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
32.66CNY
Average target price
45.80CNY
Spread / Average Target
+40.23%
High Price Target
45.80CNY
Spread / Highest target
+40.23%
Low Price Target
45.80CNY
Spread / Lowest Target
+40.23%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600329 Stock
  4. Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited